Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Dec 4, 2025 | EviCore by Evernorth | Susvimo (ranibizumab intravitreal injection via ocular implant) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Supprelin LA (histrelin acetate subcutaneous implant) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Subcutaneous Immune Globulins (Cuvitru, Hizentra, Hyqvia) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sunlenca (lenacapavir) Injection | Created |
| Dec 4, 2025 | EviCore by Evernorth | Supprelin LA (histrelin acetate) subcutaneous implant | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sunlenca (lenacapavir) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Subcutaneous Immune Globulins (Cuvitru, Hizentra, Hyqvia) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Subcutaneous Immune Globulins (Cuvitru, Hizentra, Hyqvia) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Subcutaneous Immune Globulins (Cuvitru, Hizentra, Hyqvia) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Subcutaneous Immune Globulins (Cuvitru, Hizentra, Hyqvia) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Subcutaneous Immune Globulins (Cutaquig, Cuvitru, Hizentra, HyQvia, Xembify, Gammagard Liquid, Gammaked, Gamunex-C) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Stelara (ustekinumab) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Subcutaneous Immune Globulin | Created |
| Dec 4, 2025 | EviCore by Evernorth | Subcutaneous Immune Globulin | Created |
| Dec 4, 2025 | EviCore by Evernorth | Subcutaneous Immune Globulin | Created |
| Dec 4, 2025 | EviCore by Evernorth | Stelara (ustekinumab) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Stelara (ustekinumab) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Spravato (esketamine nasal spray) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Spinraza (nusinersen) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Spravato (esketamine nasal spray) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Spevigo (spesolimab-sbzo intravenous infusion) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Spinraza (nusinersen) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Soliris (eculizumab) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Spesolimab-sbzo (Spevigo) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Specialty Drug Management Policy | Created |
| Dec 4, 2025 | EviCore by Evernorth | Specialty Drug Management Policy | Created |
| Dec 4, 2025 | EviCore by Evernorth | Specialty Drug Management Policy | Created |
| Dec 4, 2025 | EviCore by Evernorth | Soliris (eculizumab) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Somatuline Depot (lanreotide injectable) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Skyrizi Intravenous (risankizumab-rzaa) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Skyrizi (risankizumab-rzaa) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Skyrizi Intravenous (risankizumab-rzaa) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Simponi Aria (golimumab) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Simponi Aria (golimumab) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Signifor LAR (pasireotide) Injectable Suspension | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sildenafil injection (Revatio) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Signifor LAR (pasireotide) Injectable Suspension | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sildenafil injection (Revatio) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sevenfact (coagulation factor VIIa [recombinant]-jncw) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sebelipase Alfa Injections (Kanuma) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sebelipase Alfa Injections (Kanuma) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sebelipase Alfa Injections (Kanuma) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sebelipase Alfa Injections (Kanuma) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sebelipase Alfa Injections (Kanuma) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Scenesse (afamelanotide) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sebelipase Alfa Injections (Kanuma) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Saphnelo (anifrolumab-fnia) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sargramostim (Leukine) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Saphnelo (anifrolumab-fnia) | Created |
| Dec 4, 2025 | EviCore by Evernorth | Sandostatin LAR Depot (octreotide acetate) for Injectable Suspension and Sandostatin (octreotide acetate) Injection | Created |